Cargando…

MUC1 Specific Immune Responses Enhanced by Coadministration of Liposomal DDA/MPLA and Lipoglycopeptide

Mucin 1 (MUC1), a well-known tumor-associated antigen and attractive target for tumor immunotherapy, is overexpressed in most human epithelial adenomas with aberrant glycosylation. However, its low immunogenicity impedes the development of MUC1-targeted antitumor vaccines. In this study, we investig...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Jing-Jing, Zhou, Shi-Hao, Cheng, Zi-Ru, Xu, Wen-Bo, Zhang, Ru-Yan, Wang, Long-Sheng, Guo, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8854779/
https://www.ncbi.nlm.nih.gov/pubmed/35186882
http://dx.doi.org/10.3389/fchem.2022.814880

Ejemplares similares